Laboratory Medicine ›› 2021, Vol. 36 ›› Issue (5): 517-518.DOI: 10.3969/j.issn.1673-8640.2021.05.012
Previous Articles Next Articles
Received:2020-01-10
Online:2021-05-30
Published:2021-05-30
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2021.05.012
| [1] | 邹习明, 蒋彬, 邹小刚. 不同临床病理特征胃癌患者血清肿瘤标志物的表达分析[J]. 中国卫生检验杂志, 2019,29(3):317-319. |
| [2] | 徐健, 周道银, 俞靖龙, 等. 支气管肺泡灌洗液常规细胞形态学检查的临床应用价值评价[J]. 检验医学, 2012,27(3):221-224. |
| [3] | 赵家林, 黄厚章, 胡加海. 早期胃癌的诊断[J]. 中外医疗, 2011,30(3) : 93. |
| [4] | 黄厚章, 胡加海. 以腹水为首发表现的胃癌22例临床分析[J]. 中华全科医学, 2011,9(9):1403-1404. |
| [5] | 何裕隆. 胃癌病理分型研究进展[J]. 中国实用外科杂志, 2005,25(7):438-440. |
| [6] | 司岑, 杨艳丽, 李华, 等. 1 138例胃癌临床病理特征分析[J]. 宁夏医学杂志, 2014,36(11) : 982-984. |
| [7] | 汪虹, 岑红兵, 徐久元. 早期胃癌临床病理分析[J]. 检验医学与临床, 2014,11(16):2263-2264. |
| [8] | 王永才, 刘永娥, 安月, 等. 最新脱落细胞病理诊断学图谱[M]. 2版. 北京: 人民军医出版社, 2015. |
| [9] | 中华人民共和国卫生部医政司. 全国临床检验操作规程[M]. 3版. 南京: 东南大学出版社, 2006. |
| [10] | 刘超群, 韩东. 结核性胸水见类上皮细胞1例[J]. 临床检验杂志, 2016,34(6):479-480. |
| [1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
| [2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
| [3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
| [4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
| [5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
| [6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
| [7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
| [8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
| [9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
| [10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
| [11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
| [12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
| [13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
| [14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
| [15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
